Failure to inactivate CDK activity is responsible for the enhanced apoptotic response in U937 cells mediated by
Jinniu Deng1, Jianfeng Zhou, Fankai Meng
1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030.
Abstract:
Silencing ATM gene gave rise to enhanced apoptotic response to irradiation and irradiation-like chemotherapy agents, this paper explored the crucial identities of the molecular elements responsible for the enhanced apoptotic response in U937 cells mediated by silencing ATM gene. Two U937 cell mutants named U937-ASPI3K (ATM, negative) and U937-pZeosv2(+) (ATM, wild-type) were used as a cell model system to identify the critical molecule(s) responsible for the varied apoptotic response in the absence or presence of ATM gene. Apoptosis was examined by measuring concentrations of free nucleosome in U937 cells. Western blot was employed to measure nuclear protein abundance of CDC25A, CDC25B, CDC25C, total p34cdc2, p34cdc2, (Thr 161) or p34cdc2 (Thr 14, Tyr 15). RT-PCR was used to estimate CDC25 transcript levels. U937-ASPI3K exhibited an enhanced apoptotic response to lower dosage of irradiation, which could not be blocked by protein synthesis inhibitor. Protein serine-threonine phosphatase inhibitor or cyclin-dependent kinase (CDK) inhibitors, on the other hand, abolished the enhancement indicated that protein phosphorylation/dephosphorylation modification and CDK activity are required for the enhanced apoptotic response in the absence of ATM gene. Upon irradiation, p34cdc2 in U937-pZeosv2(+) was maintained in an inactive state by phosphorylation on threonine 14 (Thr 14) and tyrosine 15 (Tyr 15), which was associated with a dramatic decrease of nuclear CDC25A, CDC25B and CDC25C proteins. In contrast, p34cdc2 in U937-ASPI3K maintained in an active state by dephosphorylation on threonine 14 (Thr 14) and tyrosine 15 (Tyr 15), which was associated with constant nuclear CDC25A, CDC25B and CDC25C protein abundance before and after irradiation. The responsive decrease of nuclear CDC25 proteins occurred at the post-transcription level. Silencing ATM gene blocks the responsive decrease of nuclear CDC25 proteins, which is responsible for failure to inactivate p34cdc2 after irradiation. Active p34cdc2 and CDK2, in turn, acts as the death executors to trigger apoptosis. In summary, aberrantly activated CDK activity is the critical molecular mechanism central to enhanced apoptotic responses in the absence of ATM gene.
Insights
Silencing the ATM gene enhances apoptosis by maintaining active cyclin-dependent kinase (CDK) activity. This leads to increased cell death in response to irradiation and chemotherapy, highlighting CDK as a key molecular mechanism.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- The ATM gene plays a critical role in DNA damage response and cell cycle regulation.
- ATM deficiency can lead to altered cellular responses to genotoxic stress, including apoptosis.
- Understanding the molecular mechanisms underlying ATM-mediated apoptosis is crucial for cancer therapy.
Purpose of the Study:
- To identify the molecular factors responsible for the enhanced apoptotic response in U937 cells with silenced ATM gene.
- To investigate the role of cyclin-dependent kinase (CDK) activity and CDC25 proteins in ATM-deficient apoptosis.
- To elucidate the signaling pathways linking ATM silencing to increased radiosensitivity and chemosensitivity.
Main Methods:
- Utilized U937 cell mutants (ATM-negative and wild-type) as a model system.
- Assessed apoptosis by measuring free nucleosome concentrations.
- Employed Western blot to quantify specific protein levels (CDC25A, B, C; p34cdc2) and phosphorylation states.
- Used RT-PCR to determine CDC25 transcript levels.
Main Results:
- ATM-silenced cells (U937-ASPI3K) showed enhanced apoptosis upon irradiation, independent of protein synthesis.
- Inhibition of protein phosphatases or CDK abolished this enhancement, indicating the involvement of phosphorylation/dephosphorylation and CDK activity.
- Irradiation failed to inactivate p34cdc2 in ATM-silenced cells due to sustained nuclear CDC25 protein levels.
- Active p34cdc2 and CDK2 were identified as key executors of apoptosis in the absence of ATM.
Conclusions:
- Aberrantly activated CDK activity is the central molecular mechanism driving enhanced apoptosis in ATM-deficient cells.
- Silencing the ATM gene prevents the inactivation of p34cdc2 after irradiation by maintaining CDC25 protein levels.
- Active CDK activity acts as a critical executioner of apoptosis, contributing to increased sensitivity to irradiation and chemotherapy agents.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
Inhibition of CDK Activity


